DCM
PROF

DAFNA Capital Management’s Profound Medical PROF Stock Holding History

DAFNA Capital Management’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.73M Sell
260,360
-2,645
-1% -$17.8K 0.33% 50
2026
Q1 		$1.7M Sell
263,005
-22,705
-8% -$157K 0.39% 49
2025
Q4 		$2.25M Buy
+285,710
New +$1.84M 0.52% 46

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $476M AUM
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

DAFNA Capital Management's PROF Position: Q2 2026 in Review

DAFNA Capital Management reduced its Profound Medical (PROF) stake by 1% in Q2 2026, selling an estimated $17.8K and leaving 260,360 shares worth $1.73M. The position accounts for 0.33% of the portfolio, ranked #50.

DAFNA Capital Management first reported a position in PROF in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.25M in Q4 2025. 56 funds tracked by Wall St. Rank hold PROF as of Q2 2026.

  • DAFNA Capital Management held 260,360 shares of Profound Medical worth $1.73M as of Q2 2026.
  • DAFNA Capital Management sold 2,645 Profound Medical shares in Q2 2026, an estimated $17.8K.
  • Profound Medical made up 0.33% of DAFNA Capital Management's portfolio in Q2 2026, its #50 holding.
  • DAFNA Capital Management first reported a position in Profound Medical in Q4 2025 and has held it in 3 quarters since.
  • DAFNA Capital Management's Profound Medical position peaked at $2.25M in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Profound Medical as of Q2 2026.

Based on DAFNA Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.